Innovative Platform Oncorus specializes in IV-administered self-amplifying RNA therapeutics for cancer treatment, indicating a focus on next-generation biotech solutions that could benefit healthcare providers and research institutions seeking advanced immunotherapy options.
Funding and Revenue With a reported revenue between $10M and $50M and recent funding of $20M, Oncorus is in a growth phase, potentially seeking strategic partners or clients to support the commercialization and expansion of its innovative therapies.
Recent Financial Challenges The company has faced significant setbacks including workforce layoffs and stock decline, suggesting an urgent need for strategic collaborations and financial support to stabilize operations and accelerate product development.
Market Engagement Oncorus actively participates in investor conferences and seeks visibility among biotech investors, presenting opportunities to connect with potential partners, investors, or clients interested in cutting-edge cancer immunotherapies.
Competitive Landscape Operating within a segment with peers like Pyxis Oncology and Nurix Therapeutics, Oncorus presents opportunities for partnerships with organizations focused on viral immunotherapies and innovative biotech solutions to enhance market reach and product development.
$50M$100M
$1M$10M
$1M$10M
$50M$100M
$50M$100M
$10M$25M
$50M$100M
$1M$10MOncorus uses 8 technology products and services including Open Graph, MySQL, Bunny Fonts, and more. Explore Oncorus's tech stack below.
| Oncorus Email Formats | Percentage |
| First.Last@oncorus.com | 90% |
| FirstLast@oncorus.com | 5% |
| LastF@oncorus.com | 2% |
| First@oncorus.com | 3% |
Biotechnology ResearchUnited States51-200 Employees
Oncorus is focused on realizing the full promise of IV-administered, self-amplifying RNA medicines to transform outcomes for cancer patients. We believe this modality has the potential to safely and effectively kill tumor cells and stimulate multiple arms of the immune system to better fight cancer.
Company Overview
Funding & FinancialsOncorus has raised a total of $20M of funding over 5 rounds. Their latest funding round was raised on Apr 05, 2022 in the amount of $20M.
Oncorus's revenue is estimated to be in the range of $1M$10M
Funding & FinancialsOncorus has raised a total of $20M of funding over 5 rounds. Their latest funding round was raised on Apr 05, 2022 in the amount of $20M.
Oncorus's revenue is estimated to be in the range of $1M$10M
1-888-653-2347 
support@leadiq.com